Frazier Life Sciences Acquisition Corp. II Sets IPO Price
The company priced 7,500,000 shares at $10 each and expects the offering to close October 15, subject to conditions.
Key takeaways
- The company priced 7,500,000 Class A shares at $10 each.
- The shares are set to begin trading on Nasdaq under FLSC on October 14.
Frazier Life Sciences Acquisition Corp. II priced its initial public offering of 7,500,000 Class A ordinary shares at $10 per share. The offering is expected to close on October 15, subject to customary conditions.
The shares are set to begin trading on the Nasdaq Capital Market on October 14 under the ticker FLSC. Jefferies is acting as the sole book-running manager.
The company was formed to pursue a business combination and said it intends to focus on opportunities in biotechnology. It said its goal is to finance a company developing new therapies for patients while creating value for shareholders.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.
